Popular Anxiety Medication Recalled Nationwide over Potential Quality Issue
The voluntary recall covers 1 lot of 3 mg extended-release tablets after the FDA said the pills failed dissolution tests.
- Viatris Inc. initiated a nationwide recall for lot #8177156 of 3mg Xanax XR extended-release tablets, removing the product from circulation following identification of quality control defects.
- According to the Food and Drug Administration, the drug was recalled because it "failed dissolution specifications," a defect health officials noted could mean the pills are less effective or fail to release the correct dosage.
- Distributed nationwide between August 27, 2024, and May 29, 2025, the affected bottles carry an expiration date of February 28, 2027, according to the California State Board of Pharmacy.
- The FDA designated this as a Class II recall, which means "use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences."
- Xanax is primarily used to treat anxiety and panic disorders as a benzodiazepine that enhances neurotransmitter activity; Viatris did not immediately respond to requests for comment regarding the recall initiated last month.
87 Articles
87 Articles
Popular anxiety medication recalled nationwide over potential quality issue
A nationwide recall has been issued for a specific lot of Xanax XR, a commonly prescribed anxiety medication, after federal regulators and the drug’s manufacturer flagged a manufacturing issue involving how the tablets dissolve in the body.
Anxiety drug Xanax under nationwide recall, FDA says
Xanax 3 mg extended-release tablets with lot number 8177156 and expiration date 02/28/2027 are being recalled voluntarily by the manufacturer following FDA concerns about insufficient dissolution rates. This situation could cause temporary or reversible health effects in patients using this medication.
Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled Nationwide
The recall of the prescription-only anxiety medication was initiated by its distributor, Viatris, on March 17Prescription Medication Medicine Pill TabletsCredit: GettyNEED TO KNOWOne type of the prescription anxiety medication Xanax is being recalled nationwide3 mg tablets of the medication, sold in 60-tablet bottles, were initially recalled by its distributor, Viatris, on March 17. On April 15, the tablets were recalled nationwideThe affected m…
What you need to know about the nationwide Xanax recall
An allotment of Xanax distributed by a West Virginia-based company is being recalled nationwide, the U.S. Food and Drug Administration announced. Here's what you need to know. A benzodiazepine, Xanax and its generic form, alprazolam, are among the most widely prescribed medications for the treatment of anxiety and panic disorders. The drug, which can be [...]
Coverage Details
Bias Distribution
- 85% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


















